- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00987649
Ovarian Cancer Risk Estimation in Patients With Pelvic Mass
Evaluation of CA125 and HE4 Assays to Estimate the Risk of Ovarian Cancer in Patients Presenting to a General Surgeon or Obstetrician/Gynecologist With an Adnexal Mass
The purpose of this study is to determine whether the Risk of Ovarian Cancer Algorithm (ROMA) is effective in the determination of a woman's risk of cancer when she is scheduled to have surgery to remove a pelvic mass.
After Informed Consent is obtained, an Initial Cancer Risk Assessment will be made. A blood sample will be collected within 30 days of the surgical procedure. Results of the surgical procedure will be collected and analyzed against the CA125 and HE4 results used in the calculation of the ROMA.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
California
-
San Diego, California, Forenede Stater, 92130
- Scripps Clinic Carmel Valley
-
-
Colorado
-
Fort Collins, Colorado, Forenede Stater, 80524
- Women's Clinic of Northern Colorado
-
-
Florida
-
Jupiter, Florida, Forenede Stater, 33458
- OB/GYN Specialists of the Palm Beaches
-
Tampa, Florida, Forenede Stater, 33606
- University of South Florida Medical Center
-
-
Louisiana
-
Baton Rouge, Louisiana, Forenede Stater, 70815
- Woman's Hospital
-
-
New York
-
New York, New York, Forenede Stater, 10021
- Weill Medical College of Cornell University
-
-
North Carolina
-
Wilmington, North Carolina, Forenede Stater, 28402
- New Hanover Regional Medical Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater, 73110
- University of Oklahoma Health Sciences Center
-
-
Pennsylvania
-
Danville, Pennsylvania, Forenede Stater, 17822
- Geisinger Medical Center
-
-
Rhode Island
-
Providence, Rhode Island, Forenede Stater, 02905
- Women & Infants Hospital Rhode Island
-
-
Tennessee
-
Chattanooga, Tennessee, Forenede Stater, 37403
- Chattanooga GYN-Oncology
-
Jackson, Tennessee, Forenede Stater, 38305
- Jackson Clinic
-
Memphis, Tennessee, Forenede Stater, 38120
- Adams Patterson Gynecology & Obstetrics
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Female, age ≥ 18 years
- Adnexal mass present documented by imaging
- Scheduled to undergo surgery based on a finding of adnexal mass (defined as a simple, complex or a solid ovarian cyst/or any mass in pelvis)
- Able to understand and willing to provide Informed Consent
Exclusion Criteria:
- Previous history of ovarian cancer
- Previous history of bilateral oophorectomy
- Currently known to be pregnant
- Unable to provide informed consent
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kun etui
- Tidsperspektiver: Fremadrettet
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
1. A statistically higher number of cancer patients are correctly assigned by the combination of Initial Cancer Risk assessment and positive ROMA test result than by Initial Cancer Risk assessment alone
Tidsramme: Blood draw within 30 days of surgery
|
Blood draw within 30 days of surgery
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Richard Moore, MD, FACOG, FACS, Women & Infants Hospital Rhode Island
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Neoplasmer efter histologisk type
- Neoplasmer
- Urogenitale neoplasmer
- Neoplasmer efter sted
- Karcinom
- Neoplasmer, kirtel og epitel
- Genitale neoplasmer, kvindelige
- Sygdomme i det endokrine system
- Ovariesygdomme
- Adnexale sygdomme
- Gonadale lidelser
- Neoplasmer i endokrine kirtler
- Ovariale neoplasmer
- Karcinom, ovarieepitel
Andre undersøgelses-id-numre
- FDI-15
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .